An in vitro diagnostic test kit for the detection of carcinoembryonic antigen (CEA), a tumor marker. The product is CE certified and complies with European in vitro diagnostic product directive 98/79/EC. It is manufactured by ISO13485 certified facilities in Gothenburg, Sweden and Malvern, Pennsylva...
Manufactured by
Fujirebio Diagnostics,Inc.
China
CanAg Diagnostics (Fujirebio) is a global leader in in-vitro diagnostics and the world's largest manufacturer of tumor marker gold standards. The company provides detection products for most common solid tumors including gastrointestinal, squamous cell, liver, pancreatic, prostate, ovarian, skin, and lung cancers. All products are manufactured in ISO13485-certified facilities in Sweden and USA, supplying tumor marker antigens and antibodies to major international diagnostic manufacturers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
K.Bio Sciences Co., Ltd.
Thailand · 1 relevant product
Reagena Oy
Finland · 2 relevant products
ACON Laboratories, Inc.
United States · 2 relevant products
56 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →19 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 21 relevant matches
Fujirebio Europe · Belgium
Manual or semi-automated immunoassay kit for cancer antigen detection. Used for oncology diagnostics and tumor marker measurement.
Nanjing Poclight Biotechnology Co.,Ltd. · China
A homogeneous chemiluminescence immunoassay for CEA tumor marker detection. Applied in colorectal, lung, and breast cancer screening and post-treatment surveillance.
MedLevensohn · Brazil
A rapid diagnostic test for detecting carcinoembryonic antigen (CEA), a tumor marker used in cancer screening and monitoring.
18 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products